[Risk factor of liver disorders caused by flutamide--statistical analysis using multivariate logistic regression...

Area of Science:

• Oncology
• Hepatology
• Pharmacology

Background:

• Flutamide is a common antiandrogenic drug for prostate cancer.
• Flutamide is associated with adverse liver disorders.
• Proactive assessment of liver disorder risk before flutamide treatment is crucial.

Purpose of the Study:

• To identify risk factors for flutamide-induced liver disorders.
• To evaluate the relationship between patient history, lifestyle, and liver complications.

Main Methods:

• Retrospective survey of 123 prostate cancer patients treated with flutamide.
• Assessment of past medical history and lifestyle factors.
• Multivariate logistic regression analysis to determine risk factors.

Main Results:

• The incidence of liver disorders was 26% (33/123), with most occurring within 9 months.
• Significant risk factors identified: history of liver disorders and elevated alanine aminotransferase (ALT) levels.
• Smoking was associated with a reduced incidence of liver disorders.

Conclusions:

• A history of liver disorders and elevated ALT levels are significant predictors of flutamide-induced liver injury.
• Pre-treatment screening for liver health is recommended for patients receiving flutamide.
• Smoking may have a protective effect against flutamide-induced liver toxicity.